Study Stopped
Lack of administrative support
Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography
Objective, Prospective Measurement of Anterior Chamber Cell Grading Using Anterior Chamber Ocular Coherence Tomography
1 other identifier
interventional
6
1 country
1
Brief Summary
Optical Coherence Tomography (OCT) is routinely used in ophthalmic clinical practice. It uses infrared light to image patient's eyes. Some patients, such as those with an inflammatory disease called uveitis or those who have just undergone cataract surgery, have intraocular inflammation. This intraocular inflammation commonly manifests as cells that can be seen on routine microscopic clinical examination. However, the only currently available method to quantify this intraocular inflammation is by manually counting on the microscopic clinical examination. The investigators plan to use the OCT machine to image patient's eyes. The investigators will then use the images obtained from the OCT to objectively quantify the degree of intraocular inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 7, 2016
CompletedFirst Posted
Study publicly available on registry
September 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedResults Posted
Study results publicly available
May 6, 2019
CompletedMay 6, 2019
May 1, 2019
1.6 years
September 7, 2016
April 10, 2019
May 3, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With Identified Inflammatory Cells on OCT Scan
This measure pertains to the identification of cells in OCT scan of the participants. The inflammatory cells to be identified refer to white blood cells. The anterior segment OCT scan was used to attempt to identify these cells in the anterior chamber of the eyes of the participants.
Through study completion, up to 1 year.
Secondary Outcomes (1)
Change in Cell Density Identified by OCT Scans Over Time
Baseline and up to 8 weeks.
Study Arms (2)
Uveitis and Cataract Imaging Group
EXPERIMENTALSubjects will undergo up to three optical coherence tomography scans.
Control
EXPERIMENTALControl subjects will undergo a brief, non-contact eye exam and then undergo up to three optical coherence tomography scans.
Interventions
The OCT scan is a brief, non-contact scan of the back of the eye using infrared light. Subjects will see a light and be asked to look forwards while the scan is completed.
Eligibility Criteria
You may qualify if:
- Age over 18 years old
- Intervention Arm:
- Active anterior chamber inflammation in at least one eye as diagnosed by clinical exam
- One of the following: 1) diagnosis of uveitis OR 2) undergone cataract extraction surgery within the previous 30 days
- Control Arm:
- No active intraocular inflammation based on clinical exam
You may not qualify if:
- Corneal opacities in the affected eye
- Anyone judged unable to understand or consent to study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Doctors Office Center
Newark, New Jersey, 07101, United States
Related Publications (7)
Kempen JH, Ganesh SK, Sangwan VS, Rathinam SR. Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis. Am J Ophthalmol. 2008 Dec;146(6):813-8.e1. doi: 10.1016/j.ajo.2008.06.004. Epub 2008 Aug 8.
PMID: 18687418BACKGROUNDJabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005 Sep;140(3):509-16. doi: 10.1016/j.ajo.2005.03.057.
PMID: 16196117BACKGROUNDUser Manual: SPECTRALIS HRA+OCT. Heidelberg Engineering GmbH;2012.
BACKGROUNDAgarwal A, Ashokkumar D, Jacob S, Agarwal A, Saravanan Y. High-speed optical coherence tomography for imaging anterior chamber inflammatory reaction in uveitis: clinical correlation and grading. Am J Ophthalmol. 2009 Mar;147(3):413-416.e3. doi: 10.1016/j.ajo.2008.09.024. Epub 2008 Dec 3.
PMID: 19054493BACKGROUNDLi Y, Lowder C, Zhang X, Huang D. Anterior chamber cell grading by optical coherence tomography. Invest Ophthalmol Vis Sci. 2013 Jan 9;54(1):258-65. doi: 10.1167/iovs.12-10477.
PMID: 23249705BACKGROUNDIgbre AO, Rico MC, Garg SJ. High-speed optical coherence tomography as a reliable adjuvant tool to grade ocular anterior chamber inflammation. Retina. 2014 Mar;34(3):504-8. doi: 10.1097/IAE.0b013e31829f73bd.
PMID: 23945636BACKGROUNDSharma S, Lowder CY, Vasanji A, Baynes K, Kaiser PK, Srivastava SK. Automated Analysis of Anterior Chamber Inflammation by Spectral-Domain Optical Coherence Tomography. Ophthalmology. 2015 Jul;122(7):1464-70. doi: 10.1016/j.ophtha.2015.02.032. Epub 2015 Apr 4.
PMID: 25846846BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Insufficient enrollment and follow up leading to small numbers of subjects analyzed.
Results Point of Contact
- Title
- Dr. Elliot Crane
- Organization
- Rutgers New Jersey Medical School
Study Officials
- PRINCIPAL INVESTIGATOR
David S Chu, MD
Rutgers University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
September 7, 2016
First Posted
September 20, 2016
Study Start
September 1, 2016
Primary Completion
April 1, 2018
Study Completion
April 1, 2018
Last Updated
May 6, 2019
Results First Posted
May 6, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share